LADENBURG THALMANN FINANCIAL SERVICES INC. - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 124 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.83 and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$4,000
+300.0%
300
+971.4%
0.00%
Q1 2017$1,000
-66.7%
28
-55.6%
0.00%
Q4 2016$3,000
-75.0%
63
-71.7%
0.00%
Q3 2016$12,000
+33.3%
223
+0.5%
0.00%
Q2 2016$9,000
+200.0%
222
+200.0%
0.00%
Q1 2016$3,000740.00%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,260,000$19,921,0002.76%
BVF INC/IL 1,129,761$17,862,0001.74%
Virtus ETF Advisers LLC 46,007$727,0000.64%
BB BIOTECH AG 977,500$15,454,0000.45%
Rock Springs Capital Management LP 593,000$9,375,0000.36%
Hilltop Holdings Inc. 65,475$1,035,0000.22%
FOX RUN MANAGEMENT, L.L.C. 23,951$379,0000.12%
ARK Investment Management 183,094$2,895,0000.11%
ALGERT GLOBAL LLC 30,138$476,0000.10%
Alambic Investment Management, L.P. 22,217$351,0000.10%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders